semaglutide analog GLP-1 analogs, new trend in obesity treatment, become even more effective < Pharma < Article semaglutide glp-1 analogue Five Unexpected

Discover how PlexusDx helps you find your ideal dosing rhythm

Read about a study suggesting Wegovy reduces COVID-19 death risk, offering health benefits beyond weight loss

Dans l'ensemble, ces mdicaments populaires contre le diabte, que sont les agonistes du GLP-1 naugmentent pas le risque de cancer de la thyrode, conclut cette tude de chercheurs du Karolinska Institutet, publie dans le British Medical Journal (BMJ), qui notent nanmoins une incertitude pour certains groupes limits de patients, comme des personnes risqu congnital lev de cancer de la thyrode.

Feel lighter and more in control of your life

During the week of June 15, 2026, FDA issued 25 warning letters to telehealth companies over alleged false or misleading promotional claims about compounded GLP-1 productsclaims the agency views as violating the Federal Food, Drug, and Cosmetic Acts (FDCA) misbranding provisions, including Sections 502(a) and 502(n).